From May 23, 2024 to May 24, 2024, the company has repurchased 2,400,000 shares, representing 3.17% for ¥8,901.6 million. With this, the company has completed the repurchase of 2,400,000 shares, representing 3.17% for ¥8,901.6 million under the buyback announced on May 23, 2024.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3,752 JPY | -0.03% |
|
-0.08% | -12.97% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.97% | 1.7B | |
+55.55% | 816B | |
+41.38% | 634B | |
-6.83% | 351B | |
+17.15% | 323B | |
+7.09% | 293B | |
+13.85% | 238B | |
+1.06% | 222B | |
+13.44% | 218B | |
+7.87% | 167B |
- Stock Market
- Equities
- 4530 Stock
- News Hisamitsu Pharmaceutical Co., Inc.
- Tranche Update on Hisamitsu Pharmaceutical Co., Inc.'s Equity Buyback Plan announced on May 23, 2024.